Larry Biegelsen
Stock Analyst at Wells Fargo
(3.73)
# 831
Out of 5,041 analysts
334
Total ratings
53.56%
Success rate
6.3%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Overweight | $124 → $125 | $101.11 | +23.63% | 15 | Oct 23, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $599 → $600 | $546.51 | +9.79% | 21 | Oct 22, 2025 | |
| JNJ Johnson & Johnson | Upgrades: Overweight | $170 → $212 | $190.40 | +11.34% | 14 | Oct 3, 2025 | |
| COO The Cooper Companies | Maintains: Overweight | $93 → $72 | $73.51 | -2.05% | 18 | Aug 28, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $100 | $93.67 | +6.76% | 18 | Aug 20, 2025 | |
| HYPR Hyperfine | Maintains: Equal-Weight | $0.68 → $0.85 | $1.28 | -33.59% | 6 | Aug 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $20 → $13 | $14.95 | -13.04% | 10 | Aug 7, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $84 → $88 | $76.10 | +15.64% | 17 | Aug 7, 2025 | |
| ALC Alcon | Reinstates: Equal-Weight | $93 | $76.08 | +22.24% | 9 | Aug 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $174 → $101 | $77.52 | +30.29% | 13 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $445 | $381.79 | +16.56% | 16 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $137 → $131 | $131.91 | -0.69% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $1.64 | +82.93% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $23.02 | +4.26% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $86 → $92 | $74.67 | +23.21% | 15 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $15 | $15.52 | -3.35% | 7 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $108 → $100 | $82.74 | +20.86% | 11 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $252.99 | +14.63% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $13.75 | +5.45% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $27 | $26.00 | +3.85% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $25 → $9 | $8.61 | +4.53% | 14 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $103.03 | -4.88% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $89 | $78.14 | +13.90% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $10.46 | +62.52% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $70.33 | +33.66% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $16.11 | +204.16% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $126.85 | +7.21% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $62.29 | +12.38% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $185.83 | +45.29% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $56.06 | - | 2 | Nov 2, 2017 |
Boston Scientific
Oct 23, 2025
Maintains: Overweight
Price Target: $124 → $125
Current: $101.11
Upside: +23.63%
Intuitive Surgical
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $546.51
Upside: +9.79%
Johnson & Johnson
Oct 3, 2025
Upgrades: Overweight
Price Target: $170 → $212
Current: $190.40
Upside: +11.34%
The Cooper Companies
Aug 28, 2025
Maintains: Overweight
Price Target: $93 → $72
Current: $73.51
Upside: -2.05%
Medtronic
Aug 20, 2025
Maintains: Overweight
Price Target: $98 → $100
Current: $93.67
Upside: +6.76%
Hyperfine
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.28
Upside: -33.59%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $20 → $13
Current: $14.95
Upside: -13.04%
Edwards Lifesciences
Aug 7, 2025
Maintains: Overweight
Price Target: $84 → $88
Current: $76.10
Upside: +15.64%
Alcon
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $76.08
Upside: +22.24%
Inspire Medical Systems
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $174 → $101
Current: $77.52
Upside: +30.29%
Aug 1, 2025
Maintains: Overweight
Price Target: $435 → $445
Current: $381.79
Upside: +16.56%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $137 → $131
Current: $131.91
Upside: -0.69%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.64
Upside: +82.93%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $23.02
Upside: +4.26%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $86 → $92
Current: $74.67
Upside: +23.21%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $12 → $15
Current: $15.52
Upside: -3.35%
Jul 31, 2025
Maintains: Overweight
Price Target: $108 → $100
Current: $82.74
Upside: +20.86%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $252.99
Upside: +14.63%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $13.75
Upside: +5.45%
Jul 17, 2025
Maintains: Overweight
Price Target: $28 → $27
Current: $26.00
Upside: +3.85%
Jul 9, 2025
Downgrades: Equal-Weight
Price Target: $25 → $9
Current: $8.61
Upside: +4.53%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $103.03
Upside: -4.88%
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $78.14
Upside: +13.90%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $10.46
Upside: +62.52%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $70.33
Upside: +33.66%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $16.11
Upside: +204.16%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $126.85
Upside: +7.21%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $62.29
Upside: +12.38%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $185.83
Upside: +45.29%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $56.06
Upside: -